Transcriptional control by cell-cycle regulators: A review

Journal of Cellular Physiology

Volumn 179, Issue 2, 1999, Pages 134-141

  Lania, Luigi ^a   Majello, Barbara ^b   Napolitano, Giuliana ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLINE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; GENE EXPRESSION REGULATION; GENE REPRESSION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION;

CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0032936349     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199905)179:2<134::AID-JCP3>3.0.CO;2-O     Document Type: Review

References (67)

1. Adnane J, Shao Z, Robbins PD. 1995. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J Biol Chem 270:8837-8843.
2. Bartek J, Bartkova J, Lukas J. 1996. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 8:805-814.
3. Brehm A, Miska EA, McCance DJ, Reid J, Bannister AJ, Kouzarides T. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
4. Bremner R, Cohen BL, Sopta M, Hamel PA, Ingles CJ, Gallie BL, Phillips RA. 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol 15:3256-3265.
5. Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov G, Rothblum LI. 1995. Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature 374:177-180.
6. Chow KN, Dean DC. 1996. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol 16:4862-4868.
7. Chow KN, Starostik P, Dean DC, 1996. The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. Mol Cell Biol 16:7173-7181.
8. Cismowsky MJ, Laff GM, Solomon MJ, Reed SI. 1995. Kin28 encodes a C-terminal domain kinase that controls mRNA transcription in Saccharomices cerevisiae but lacks cyclin-dependent kinase-activating kinase (CAK) activity. Mol Cell Biol 15:2983-2992.
9. Cullen BR. 1998. HIV-1 auxiliary proteins: making connections in a dying cell. Cell 93:685-692.
10. Dahmus ME. 1996. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J Biol Chem 271:19009-19012.
11. De Falco G, Giordano A. 1998. CDK9 (PITALRE): a multifunctional cdc2-related kinase. J Cell Physiol 177:501-506.
12. De Luca P, Majello B, Lania L. 1998. Retinoblastoma protein tethered to promoter DNA represses TBP-mediated transcription. J Cell Biochem 70:281-287.
13. Devault A, Martinez AM, Fesquet D, Labbe JC, Morin N, Tassan JP, Nigg EA, Cavadore JC, Doree M. 1995. MAT1 ('menage a trois') a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO J 14:5027-5036.
14. Dynlacht BD. 1997. Regulation of transcription by proteins that control the cell cycle. Nature 389:149-152.
15. Dyson N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262.
16. Espinoza FH, Farrell A, Erdjument-Bromage H, Tempst P, Morgan DO. 1996. A cyclin-dependent kinase-activating kinase (CAK) in budding yeast unrelated to vertebrate CAK. Science 273:1714-1717.
17. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D. 1998. The three members of the pocket family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA 95:10493-10498.
18. Fisher RP. 1997. CDKs and cyclins in transition(s). Curr Opin Genet Dev 7:32-38.
19. Fisher RP, Morgan DO. 1994. A novel cyclin associates with MO15/ CDK7 to form the CDK-activating kinase. Cell 78:713-724.
20. Fisher RP, Jin P, Chamberlin HM, Morgan DO. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83:47-57.
21. Gold MO, Rice AP. 1998. Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression. Nucleic Acids Res 26:3784-3788.
22. Gold MO, Tassan J-P, Nigg EA, Rice AP, Hermann CH. 1996. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8. Nucleic Acid Res 24:3771-3777.
23. Gold MO, Yang X, Herrmann CH, Rice AP. 1998. PITALRE, the catalytic subunit of tak, is required for human immunodeficiency virus Tat transactivation in vivo. J Virol 72:4448-4453.
24. Grana X, De Luca A, Sang N, Fu Y, Claudio PP, Rosenblatt J, Morgan DO, Giordano A. 1994. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci USA 91:3834-3848.
25. Harper JW, Elledge SJ. 1998. The role of Cdk7 in CAK function, a retro-retrospective. Genes Dev 12:285-289.
26. Helin K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8:28-35.
27. Helin K, Harlow E, Fattaey A. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13:6501-6508.
28. Hengartner CJ, Meyer VE, Liao S-M, Wilson CJ, Koh SS, Young RA. 1998. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol Cell 2:43-53.
29. Herrmann CH, Rice AP. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J Virol 69:1612-1620.
30. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177-185.
31. Jones KA. 1997. Taking a new TAK on tat transactivation. Genes Dev 11:2593-2599.
32. Jones KA, Peterlin BM. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63:717-743.
33. Kaldis P, Sutton A, Solomon MJ. 1996. The Cdk-activating kinase (CAK) from budding yeast. Cell 86:553-564.
34. Koleske AJ, Young RA. 1995. The RNA polymerase II holoenzyme and its implications for gene regulation. Trends Biochem Sci 20:113-116.
35. Lee D, Lis JT. 1998. Transcriptional activation independent of TFIIH kinase and the RNA polymerase mediator in vivo. Nature 393:389-392.
36. Liao SM, Zhang J, Jeffery DA, Koleske AJ, Thompson CM, Chao DM, Viljoen M, van Vuuren HJ, Young RA. 1995. A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature 374:193-196.
37. Luo RX, Postigo AA, Dean DC. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
38. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, LeVillai JP, Troalen F, Trouche D, Harel-Bellan A. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-604.
39. Maldonado E, Shiekhattar R, Sheldon M, Cho H, Drapkin R, Rickert P, Lees E, Anderson CW, Linn S, Reinberg D. 1996. A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature 381:86-89.
40. Mancebo HS, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Hazuda D, Price D, Flores O. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 11:2633-2644.
41. McNeil JB, Agah H, Bentley D. 1998. Activated transcription independent of the RNA polymerase II holoenzyme in budding east. Genes Dev 16:2510-2521.
42. Morgan DO. 1995. Principles of CDK regulation. Nature 374:131-134.
43. Myer VE, Young RA. 1998. RNA polymerase holoenzymes and sub-complexes. J Biol Chem 273:27757-27760.
44. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17:5338-5347.
45. Okamoto H, Sheline C, Corden J, Jones K, Peterlin B. 1996. Transactivation of human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc Natl Acad Sci USA 93:11575-11579.
46. Paggi MG, Baldi A, Bonetto F, Giordano A. 1996. Retinoblastoma protein family in cell cycle and cancer: A review. J Cell Biochem 62:418-430.
47. Pazin MJ, Kadonaga JT. 1997. What's up and down with histone deacetylation and transcription? Cell 89:325-328.
48. Peeper DS, Parker LL, Ewen ME, Toebes M, Hall FL, Xu M, Zantema A, van-der-Eb AJ, Piwnica-Worms H. 1993. A-and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J 12:1947-1954.
49. Peng J, Marshall NF, Price DH. 1998. Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J Biol Chem 273:13855-13860.
50. Rickert P, Seghezzi W, Shanahan F, Lees E. 1996. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 12:2631-2640.
51. Roy R, Adamczewski JP, Seroz T, Vermeulen W, Tassan JP, Schaeffer L, Nigg EA, Hoeijmakers JH, Egly JM. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79:1093-1101.
52. Sellers WR, Rodgers JW, Kaelin W Jr. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci USA 92:11544-11548.
53. Sherr CJ, 1996. Cancer cell cycles. Science 274:1672-1677.
54. Svejstrup JQ, Li Y, Fellows J, Gnatt A, Bjorklund S, Kornberg RD. 1997. Evidence for a mediator cycle at the initiation of transcription. Proc Natl Acad Sci USA 94:6075-6078.
55. Tassan J-P, Jaquenoud M, Leopold P, Schultz SJ, Nigg EA. 1995. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc Natl Acad Sci USA 86:8871-8875.
56. Thuret JY, Valay JG, Faye G, Mann C. 1996. Civ1 (CAK in vivo), a novel Cdk-activating kinase. Cell 86:565-576.
57. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
58. Weinberg RA. 1995. The retinoblastoma protein and cell cycle. Cell 81:323-330.
59. Weintraub SJ, Prater CA, Dean DC. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261.
60. Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815.
61. White RJ, Trouche D, Martin K, Jackson SP, Kouzarides T. 1996. Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature 382:88-90.
62. Wolffe AP, Pruss D. 1996. Targeting chromatin disruption: transcription regulators that acetylase histones. Cell 84:817-819.
63. Zawel L, Kumar KP, Reinberg D. 1995. Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev 9:1479-1490.
64. Zhou Q, Sharp PA. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J 14:321-328.
65. Zhou Q, Chen D, Pierstorff E, Luo K. 1998. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J 17:3681-3691.
66. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH. 1997. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev 11:2622-2632.
67. Zwijsen RM, Wientjens E, Klompmaker R, van-der-Sman J, Bernards R, Michalides RJ. 1997. CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415.